back to cluster viewer
cluster path 111010001110110
203 words, 10,087 tokens
freq alpha suffix
Words in frequency order
1 | responsible | 5,709
|
2 | accounted | 2,318
|
3 | accounts | 1,070
|
4 | reserved | 633
|
5 | dispensable | 74
|
6 | compensates | 48
|
7 | faulted | 5
|
8 | gu/ml | 4
|
9 | hxμg/ml | 4
|
10 | ngxh/ml | 4
|
11 | overbmi | 4
|
12 | pleads | 3
|
13 | µg/m3×s | 3
|
14 | *tev | 2
|
15 | +rbv | 2
|
16 | .nnts | 2
|
17 | /acetonitrile | 2
|
18 | accede | 2
|
19 | congratulated | 2
|
20 | decays/mbq | 2
|
21 | guidelines-discordant | 2
|
22 | h-ng/ml | 2
|
23 | h×ng/ml | 2
|
24 | microj/cm2 | 2
|
25 | nuts+/-ys | 2
|
26 | overanticoagulated | 2
|
27 | pre-etched | 2
|
28 | responsable | 2
|
29 | teletherapies | 2
|
30 | µg/h/l | 2
|
31 | μgh/ml | 2
|
32 | +7.92 | 1
|
33 | -0.05±0.2 | 1
|
34 | -0.76±1.04 | 1
|
35 | -26.8±18.1 | 1
|
36 | -29.48±2.16 | 1
|
37 | -6·1° | 1
|
38 | -9.2±4.5 | 1
|
39 | -acetyl-β-lysine | 1
|
40 | -alpha2a | 1
|
41 | -chop-14 | 1
|
42 | -csfs | 1
|
43 | -gggta | 1
|
44 | -nm | 1
|
45 | .families | 1
|
46 | .mobilisation | 1
|
47 | .recommendations | 1
|
48 | .s | 1
|
49 | .withdrawals | 1
|
50 | /c-statistic | 1
|
51 | /fsh | 1
|
52 | 0,73±0,33mm | 1
|
53 | 0.01-5ng/ml | 1
|
54 | 0.13° | 1
|
55 | 0.1653 | 1
|
56 | 0.33-1.0 | 1
|
57 | 0.52db/cm | 1
|
58 | 0.625:1 | 1
|
59 | 0.67+/-0.01 | 1
|
60 | 1.08/1.05/1.11 | 1
|
61 | 1.31±0.64 | 1
|
62 | 1.7+/-2.3 | 1
|
63 | 1/2-inhibitor | 1
|
64 | 11,08 | 1
|
65 | 12.0+/-94 | 1
|
66 | 131.856±8.050ng/ml | 1
|
67 | 137.1h | 1
|
68 | 14.12-18.41 | 1
|
69 | 14.7h | 1
|
70 | 144.5h | 1
|
71 | 18.85°c | 1
|
72 | 2,797.74 | 1
|
73 | 2.0µg/ml | 1
|
74 | 2.2min+/-1.0 | 1
|
75 | 2.4002 | 1
|
76 | 2.53+/-0.15 | 1
|
77 | 2.67±0.96 | 1
|
78 | 2.9±2.1 | 1
|
79 | 20.53+/-15.07 | 1
|
80 | 21u/l | 1
|
81 | 257±154days | 1
|
82 | 3.2±5.5 | 1
|
83 | 3.3kg | 1
|
84 | 3.896 | 1
|
85 | 30.88±1.39 | 1
|
86 | 31,615 | 1
|
87 | 3days/wk | 1
|
88 | 3·0° | 1
|
89 | 42.5°-43°c | 1
|
90 | 425.2n | 1
|
91 | 5.2957 | 1
|
92 | 5.7±2.0 | 1
|
93 | 585.6 | 1
|
94 | 6,912 | 1
|
95 | 60gy/30fx | 1
|
96 | 7.654 | 1
|
97 | 8.25±1.46 | 1
|
98 | 8.71±1.285 | 1
|
99 | 843.7miu/ml | 1
|
100 | 9,96 | 1
|
101 | 9.1-16.9 | 1
|
102 | 9.7e-07 | 1
|
103 | 92.1mg/dl | 1
|
104 | 96904 | 1
|
105 | 985°c | 1
|
106 | =.905 | 1
|
107 | =0.846 | 1
|
108 | =1.01-1.79 | 1
|
109 | =30.35μm | 1
|
110 | adhesive/mixture | 1
|
111 | ag100a | 1
|
112 | amaintained | 1
|
113 | ampicillin-cloxacillin | 1
|
114 | and-shown | 1
|
115 | and.005 | 1
|
116 | archosaur | 1
|
117 | avoided-either | 1
|
118 | barometers | 1
|
119 | cauterised | 1
|
120 | centrifugated | 1
|
121 | chanchroid | 1
|
122 | circularized | 1
|
123 | clemped | 1
|
124 | component-amplitudes | 1
|
125 | conttraindicated | 1
|
126 | correctable-problem | 1
|
127 | disingenuous | 1
|
128 | dsbs/100mbp/gy | 1
|
129 | dystonicus | 1
|
130 | ear-drops | 1
|
131 | egg-patent | 1
|
132 | electable | 1
|
133 | eur9,258,000 | 1
|
134 | euro2421 | 1
|
135 | euro75,000 | 1
|
136 | fluorophosphonate | 1
|
137 | forgiven | 1
|
138 | garcke | 1
|
139 | geoglobus | 1
|
140 | grunntest | 1
|
141 | guideline-supported | 1
|
142 | hentschel | 1
|
143 | homodirectional | 1
|
144 | iinvestigated | 1
|
145 | lyzed | 1
|
146 | marshalled | 1
|
147 | medium-refer | 1
|
148 | minores | 1
|
149 | mis-incorporated | 1
|
150 | ms·ml/µg | 1
|
151 | mumol/mol | 1
|
152 | n/cm².s | 1
|
153 | nct01313624 | 1
|
154 | ngãh/ml | 1
|
155 | nnyag | 1
|
156 | non-intuitive | 1
|
157 | nullisomic | 1
|
158 | penetrable-since | 1
|
159 | pfbs/kg/day | 1
|
160 | post-accelerator | 1
|
161 | prescibed | 1
|
162 | pretyped | 1
|
163 | pristinamycine | 1
|
164 | q12h×6+daunorubicin | 1
|
165 | qbes | 1
|
166 | rectoanastomosis | 1
|
167 | relabelled | 1
|
168 | releaved | 1
|
169 | reperformed | 1
|
170 | respnsible | 1
|
171 | risk-effective | 1
|
172 | s-methionine/cysteine | 1
|
173 | sakalava | 1
|
174 | self-organizes | 1
|
175 | singns | 1
|
176 | sjgiilar | 1
|
177 | smacked | 1
|
178 | standed | 1
|
179 | statistic=1.037 | 1
|
180 | t7-t8 | 1
|
181 | to.79 | 1
|
182 | under-prepared | 1
|
183 | undisrupted | 1
|
184 | vp/day | 1
|
185 | weight-standardized | 1
|
186 | wistful | 1
|
187 | yearned | 1
|
188 | zero-even | 1
|
189 | £171.36 | 1
|
190 | £6906 | 1
|
191 | ±5,990 | 1
|
192 | ±74,493 | 1
|
193 | ×uln | 1
|
194 | μmol·h/l | 1
|
195 | €1,866 | 1
|
196 | €11,947 | 1
|
197 | €11.7 | 1
|
198 | €26,499 | 1
|
199 | €26,725 | 1
|
200 | €9555 | 1
|
201 | −0.26 | 1
|
202 | ≤0.26 | 1
|
203 | ≥60mg/l | 1
|
Words in alphabetical order
1 | *tev | 2
|
2 | +7.92 | 1
|
3 | +rbv | 2
|
4 | -0.05±0.2 | 1
|
5 | -0.76±1.04 | 1
|
6 | -26.8±18.1 | 1
|
7 | -29.48±2.16 | 1
|
8 | -6·1° | 1
|
9 | -9.2±4.5 | 1
|
10 | -acetyl-β-lysine | 1
|
11 | -alpha2a | 1
|
12 | -chop-14 | 1
|
13 | -csfs | 1
|
14 | -gggta | 1
|
15 | -nm | 1
|
16 | .families | 1
|
17 | .mobilisation | 1
|
18 | .nnts | 2
|
19 | .recommendations | 1
|
20 | .s | 1
|
21 | .withdrawals | 1
|
22 | /acetonitrile | 2
|
23 | /c-statistic | 1
|
24 | /fsh | 1
|
25 | 0,73±0,33mm | 1
|
26 | 0.01-5ng/ml | 1
|
27 | 0.13° | 1
|
28 | 0.1653 | 1
|
29 | 0.33-1.0 | 1
|
30 | 0.52db/cm | 1
|
31 | 0.625:1 | 1
|
32 | 0.67+/-0.01 | 1
|
33 | 1.08/1.05/1.11 | 1
|
34 | 1.31±0.64 | 1
|
35 | 1.7+/-2.3 | 1
|
36 | 1/2-inhibitor | 1
|
37 | 11,08 | 1
|
38 | 12.0+/-94 | 1
|
39 | 131.856±8.050ng/ml | 1
|
40 | 137.1h | 1
|
41 | 14.12-18.41 | 1
|
42 | 14.7h | 1
|
43 | 144.5h | 1
|
44 | 18.85°c | 1
|
45 | 2,797.74 | 1
|
46 | 2.0µg/ml | 1
|
47 | 2.2min+/-1.0 | 1
|
48 | 2.4002 | 1
|
49 | 2.53+/-0.15 | 1
|
50 | 2.67±0.96 | 1
|
51 | 2.9±2.1 | 1
|
52 | 20.53+/-15.07 | 1
|
53 | 21u/l | 1
|
54 | 257±154days | 1
|
55 | 3.2±5.5 | 1
|
56 | 3.3kg | 1
|
57 | 3.896 | 1
|
58 | 30.88±1.39 | 1
|
59 | 31,615 | 1
|
60 | 3days/wk | 1
|
61 | 3·0° | 1
|
62 | 42.5°-43°c | 1
|
63 | 425.2n | 1
|
64 | 5.2957 | 1
|
65 | 5.7±2.0 | 1
|
66 | 585.6 | 1
|
67 | 6,912 | 1
|
68 | 60gy/30fx | 1
|
69 | 7.654 | 1
|
70 | 8.25±1.46 | 1
|
71 | 8.71±1.285 | 1
|
72 | 843.7miu/ml | 1
|
73 | 9,96 | 1
|
74 | 9.1-16.9 | 1
|
75 | 9.7e-07 | 1
|
76 | 92.1mg/dl | 1
|
77 | 96904 | 1
|
78 | 985°c | 1
|
79 | =.905 | 1
|
80 | =0.846 | 1
|
81 | =1.01-1.79 | 1
|
82 | =30.35μm | 1
|
83 | accede | 2
|
84 | accounted | 2,318
|
85 | accounts | 1,070
|
86 | adhesive/mixture | 1
|
87 | ag100a | 1
|
88 | amaintained | 1
|
89 | ampicillin-cloxacillin | 1
|
90 | and-shown | 1
|
91 | and.005 | 1
|
92 | archosaur | 1
|
93 | avoided-either | 1
|
94 | barometers | 1
|
95 | cauterised | 1
|
96 | centrifugated | 1
|
97 | chanchroid | 1
|
98 | circularized | 1
|
99 | clemped | 1
|
100 | compensates | 48
|
101 | component-amplitudes | 1
|
102 | congratulated | 2
|
103 | conttraindicated | 1
|
104 | correctable-problem | 1
|
105 | decays/mbq | 2
|
106 | disingenuous | 1
|
107 | dispensable | 74
|
108 | dsbs/100mbp/gy | 1
|
109 | dystonicus | 1
|
110 | ear-drops | 1
|
111 | egg-patent | 1
|
112 | electable | 1
|
113 | eur9,258,000 | 1
|
114 | euro2421 | 1
|
115 | euro75,000 | 1
|
116 | faulted | 5
|
117 | fluorophosphonate | 1
|
118 | forgiven | 1
|
119 | garcke | 1
|
120 | geoglobus | 1
|
121 | grunntest | 1
|
122 | gu/ml | 4
|
123 | guideline-supported | 1
|
124 | guidelines-discordant | 2
|
125 | h-ng/ml | 2
|
126 | hentschel | 1
|
127 | homodirectional | 1
|
128 | hxμg/ml | 4
|
129 | h×ng/ml | 2
|
130 | iinvestigated | 1
|
131 | lyzed | 1
|
132 | marshalled | 1
|
133 | medium-refer | 1
|
134 | microj/cm2 | 2
|
135 | minores | 1
|
136 | mis-incorporated | 1
|
137 | ms·ml/µg | 1
|
138 | mumol/mol | 1
|
139 | n/cm².s | 1
|
140 | nct01313624 | 1
|
141 | ngxh/ml | 4
|
142 | ngãh/ml | 1
|
143 | nnyag | 1
|
144 | non-intuitive | 1
|
145 | nullisomic | 1
|
146 | nuts+/-ys | 2
|
147 | overanticoagulated | 2
|
148 | overbmi | 4
|
149 | penetrable-since | 1
|
150 | pfbs/kg/day | 1
|
151 | pleads | 3
|
152 | post-accelerator | 1
|
153 | pre-etched | 2
|
154 | prescibed | 1
|
155 | pretyped | 1
|
156 | pristinamycine | 1
|
157 | q12h×6+daunorubicin | 1
|
158 | qbes | 1
|
159 | rectoanastomosis | 1
|
160 | relabelled | 1
|
161 | releaved | 1
|
162 | reperformed | 1
|
163 | reserved | 633
|
164 | respnsible | 1
|
165 | responsable | 2
|
166 | responsible | 5,709
|
167 | risk-effective | 1
|
168 | s-methionine/cysteine | 1
|
169 | sakalava | 1
|
170 | self-organizes | 1
|
171 | singns | 1
|
172 | sjgiilar | 1
|
173 | smacked | 1
|
174 | standed | 1
|
175 | statistic=1.037 | 1
|
176 | t7-t8 | 1
|
177 | teletherapies | 2
|
178 | to.79 | 1
|
179 | under-prepared | 1
|
180 | undisrupted | 1
|
181 | vp/day | 1
|
182 | weight-standardized | 1
|
183 | wistful | 1
|
184 | yearned | 1
|
185 | zero-even | 1
|
186 | £171.36 | 1
|
187 | £6906 | 1
|
188 | ±5,990 | 1
|
189 | ±74,493 | 1
|
190 | µg/h/l | 2
|
191 | µg/m3×s | 3
|
192 | ×uln | 1
|
193 | μgh/ml | 2
|
194 | μmol·h/l | 1
|
195 | €1,866 | 1
|
196 | €11,947 | 1
|
197 | €11.7 | 1
|
198 | €26,499 | 1
|
199 | €26,725 | 1
|
200 | €9555 | 1
|
201 | −0.26 | 1
|
202 | ≤0.26 | 1
|
203 | ≥60mg/l | 1
|
Words in suffix order
1 | 2.2min+/-1.0 | 1
|
2 | 0.33-1.0 | 1
|
3 | 5.7±2.0 | 1
|
4 | euro75,000 | 1
|
5 | eur9,258,000 | 1
|
6 | ±5,990 | 1
|
7 | 2.9±2.1 | 1
|
8 | -26.8±18.1 | 1
|
9 | 0.67+/-0.01 | 1
|
10 | 1.08/1.05/1.11 | 1
|
11 | euro2421 | 1
|
12 | 14.12-18.41 | 1
|
13 | 0.625:1 | 1
|
14 | -0.05±0.2 | 1
|
15 | 2.4002 | 1
|
16 | 6,912 | 1
|
17 | +7.92 | 1
|
18 | microj/cm2 | 2
|
19 | 1.7+/-2.3 | 1
|
20 | 0.1653 | 1
|
21 | ±74,493 | 1
|
22 | -0.76±1.04 | 1
|
23 | 96904 | 1
|
24 | -chop-14 | 1
|
25 | nct01313624 | 1
|
26 | 7.654 | 1
|
27 | 1.31±0.64 | 1
|
28 | 2,797.74 | 1
|
29 | 12.0+/-94 | 1
|
30 | -9.2±4.5 | 1
|
31 | 3.2±5.5 | 1
|
32 | and.005 | 1
|
33 | =.905 | 1
|
34 | 2.53+/-0.15 | 1
|
35 | 31,615 | 1
|
36 | €26,725 | 1
|
37 | €9555 | 1
|
38 | 8.71±1.285 | 1
|
39 | 585.6 | 1
|
40 | £6906 | 1
|
41 | -29.48±2.16 | 1
|
42 | −0.26 | 1
|
43 | ≤0.26 | 1
|
44 | £171.36 | 1
|
45 | 8.25±1.46 | 1
|
46 | =0.846 | 1
|
47 | €1,866 | 1
|
48 | 9,96 | 1
|
49 | 2.67±0.96 | 1
|
50 | 3.896 | 1
|
51 | €11.7 | 1
|
52 | 9.7e-07 | 1
|
53 | 20.53+/-15.07 | 1
|
54 | statistic=1.037 | 1
|
55 | €11,947 | 1
|
56 | 5.2957 | 1
|
57 | 11,08 | 1
|
58 | t7-t8 | 1
|
59 | 9.1-16.9 | 1
|
60 | 30.88±1.39 | 1
|
61 | =1.01-1.79 | 1
|
62 | to.79 | 1
|
63 | €26,499 | 1
|
64 | ag100a | 1
|
65 | -alpha2a | 1
|
66 | -gggta | 1
|
67 | sakalava | 1
|
68 | nullisomic | 1
|
69 | /c-statistic | 1
|
70 | 42.5°-43°c | 1
|
71 | 18.85°c | 1
|
72 | 985°c | 1
|
73 | prescibed | 1
|
74 | standed | 1
|
75 | pre-etched | 2
|
76 | smacked | 1
|
77 | marshalled | 1
|
78 | relabelled | 1
|
79 | reperformed | 1
|
80 | amaintained | 1
|
81 | yearned | 1
|
82 | clemped | 1
|
83 | pretyped | 1
|
84 | under-prepared | 1
|
85 | cauterised | 1
|
86 | conttraindicated | 1
|
87 | iinvestigated | 1
|
88 | centrifugated | 1
|
89 | overanticoagulated | 2
|
90 | congratulated | 2
|
91 | mis-incorporated | 1
|
92 | faulted | 5
|
93 | accounted | 2,318
|
94 | undisrupted | 1
|
95 | guideline-supported | 1
|
96 | releaved | 1
|
97 | reserved | 633
|
98 | weight-standardized | 1
|
99 | circularized | 1
|
100 | lyzed | 1
|
101 | chanchroid | 1
|
102 | penetrable-since | 1
|
103 | accede | 2
|
104 | garcke | 1
|
105 | dispensable | 74
|
106 | responsable | 2
|
107 | electable | 1
|
108 | responsible | 5,709
|
109 | respnsible | 1
|
110 | /acetonitrile | 2
|
111 | pristinamycine | 1
|
112 | s-methionine/cysteine | 1
|
113 | -acetyl-β-lysine | 1
|
114 | adhesive/mixture | 1
|
115 | fluorophosphonate | 1
|
116 | risk-effective | 1
|
117 | non-intuitive | 1
|
118 | nnyag | 1
|
119 | 3.3kg | 1
|
120 | ms·ml/µg | 1
|
121 | 137.1h | 1
|
122 | 144.5h | 1
|
123 | 14.7h | 1
|
124 | /fsh | 1
|
125 | overbmi | 4
|
126 | 3days/wk | 1
|
127 | ≥60mg/l | 1
|
128 | µg/h/l | 2
|
129 | μmol·h/l | 1
|
130 | 21u/l | 1
|
131 | homodirectional | 1
|
132 | 92.1mg/dl | 1
|
133 | hentschel | 1
|
134 | h-ng/ml | 2
|
135 | 131.856±8.050ng/ml | 1
|
136 | 0.01-5ng/ml | 1
|
137 | h×ng/ml | 2
|
138 | 2.0µg/ml | 1
|
139 | hxμg/ml | 4
|
140 | μgh/ml | 2
|
141 | ngxh/ml | 4
|
142 | ngãh/ml | 1
|
143 | gu/ml | 4
|
144 | 843.7miu/ml | 1
|
145 | mumol/mol | 1
|
146 | wistful | 1
|
147 | 0.52db/cm | 1
|
148 | correctable-problem | 1
|
149 | 0,73±0,33mm | 1
|
150 | -nm | 1
|
151 | =30.35μm | 1
|
152 | 425.2n | 1
|
153 | zero-even | 1
|
154 | forgiven | 1
|
155 | q12h×6+daunorubicin | 1
|
156 | ampicillin-cloxacillin | 1
|
157 | ×uln | 1
|
158 | .mobilisation | 1
|
159 | and-shown | 1
|
160 | decays/mbq | 2
|
161 | sjgiilar | 1
|
162 | medium-refer | 1
|
163 | avoided-either | 1
|
164 | post-accelerator | 1
|
165 | 1/2-inhibitor | 1
|
166 | archosaur | 1
|
167 | .s | 1
|
168 | n/cm².s | 1
|
169 | pleads | 3
|
170 | qbes | 1
|
171 | component-amplitudes | 1
|
172 | .families | 1
|
173 | teletherapies | 2
|
174 | minores | 1
|
175 | compensates | 48
|
176 | self-organizes | 1
|
177 | -csfs | 1
|
178 | rectoanastomosis | 1
|
179 | .withdrawals | 1
|
180 | singns | 1
|
181 | .recommendations | 1
|
182 | ear-drops | 1
|
183 | barometers | 1
|
184 | .nnts | 2
|
185 | accounts | 1,070
|
186 | geoglobus | 1
|
187 | dystonicus | 1
|
188 | disingenuous | 1
|
189 | nuts+/-ys | 2
|
190 | 257±154days | 1
|
191 | µg/m3×s | 3
|
192 | guidelines-discordant | 2
|
193 | egg-patent | 1
|
194 | grunntest | 1
|
195 | +rbv | 2
|
196 | *tev | 2
|
197 | 60gy/30fx | 1
|
198 | pfbs/kg/day | 1
|
199 | vp/day | 1
|
200 | dsbs/100mbp/gy | 1
|
201 | 3·0° | 1
|
202 | -6·1° | 1
|
203 | 0.13° | 1
|